Carlsbad Technology Inc - Company Review
SummaryCarlsbad Technology Inc - Company Review
Summary
Carlsbad Technology Inc (Carlsbad), a subsidiary of Yung Shin Pharma Ind Co Ltd is a healthcare products provider that offers generic formulations. The company offers generic prescription drugs which include acyclovir tablets, acyclovir capsules, carisoprodol tablets, cefaclor capsules, ciproxfloxacin tablets, clonidine hydrochloride tablets, diclofenac sodium tablets, famotidine tablets, glimepiride tablets, lovastatin tablets, levocetirizine dihydrochloride tablets, meloxicam tablets, metformin hydrochloride tablets, and nevirapine tablets. It sells products through a network of distributors in the US and Puerto Rico. Carlsbad is headquartered in Carlsbad, California, the US.
This comprehensive company report of Carlsbad Technology Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.